Trial no.:
|
PACTR201802002998973 |
Date of Approval:
|
21/01/2018 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Milrinone in status asthmaticus |
Official scientific title |
The use of Milrinone versus conventional treatment for the management of life-threatening bronchial asthma |
Brief summary describing the background
and objectives of the trial
|
most asthma can be controlled with medication an estimated 5-10% of the USA asthma and world population is considered to have the most severe persistent form of the disease that does not respond well to treatment. These people are likely to have more attacks and are more at risk of a fatal attack.In the past 25 years literature has hinted at the therapeutic potential of phosphodiesterase inhibitors in asthma.
The purpose of this study is to assess the effectiveness of using milrinone as a rescue drug in life-threatening bronchial asthma
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
bronchial asthma,Respiratory |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
02/10/2017 |
Actual trial start date |
11/11/2017 |
Anticipated date of last follow up |
03/03/2018 |
Actual Last follow-up date |
18/01/2018 |
Anticipated target sample size (number of participants) |
50 |
Actual target sample size (number of participants) |
50 |
Recruitment status |
Completed |
Publication URL |
|
|